Search Results - Sninska, Zuzana

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study

    Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of t... by Skopec, Barbara, Sninska, Zuzana, Tzvetkov, Nikolai, Ivanushkin, Vladlen, Björklöf, Katja, Hippenmeyer, Jane, Mihaylov, Georgi

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK)

    Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK) by Sninska, Zuzana, Mistrik, Martin, Slezakova, Katarina, Demitrovicova, Ludmila, Mikuskova, Eva, Markuljak, Imrich, Chudej, Juraj, Stecova, Natalia, Tothova, Elena, Kafkova, Adriana, Palasthy, Stanislav, Lesko-Andrascikova, Jana, Necasova, Tereza, Koritakova, Eva

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia: An observational, nonintervention study of real-life practice

    PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia: An observational, nonintervention study of real-life practice by Mihaylov, Georgi, Skopec, Barbara, Sninska, Zuzana, Tzvetkov, Nikolai, Cerna, Olga, Ivanushkin, Vladlen, Niepel, Daniela, Björklöf, Katja, Černelč, Peter

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Evaluation of 5‐year imatinib treatment of 458 patients with CP‐CML in routine clinical practice and prognostic impact of different BCR‐ABL cutoff levels

    Evaluation of 5‐year imatinib treatment of 458 patients with CP‐CML in routine clinical practice and prognostic impact of different BCR‐ABL cutoff levels by Klamová, Hana, Poláková, Kateřina Machová, Mužík, Jan, Ráčil, Zdeněk, Žáčková, Daniela, Steinerová, Kateřina, Karas, Michal, Faber, Edgar, Demečková, Eva, Michalovičová‐Sninská, Zuzana, Voglová, Jaroslava, Demitrovičová, Ľudmila, Mikušková, Eva, Tóthová, Elena, Chudej, Juraj, Markuljak, Imrich, Cmunt, Eduard, Moravcová, Jana, Dvořáková, Dana, Michalová, Kyra, Jarošová, Marie, Šťastná, Markéta Marková, Cetkovský, Petr, DuŠek, Ladislav, Koza, Vladimír, Trněný, Marek, Indrák, Karel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry

    Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry by Hoffmann, Verena Sophia, Baccarani, Michele, Hasford, Joerg, Lindoerfer, Doris, Burgstaller, Sonja, Sertic, Dubravka, Costeas, Paul, Mayer, Jiri, Indrak, Karel, Everaus, Hele, Koskenvesa, Perttu, Guilhot, Joelle, Schubert-Fritschle, Gabriele, Castagnetti, Fausto, Di Raimondo, Francesco, Lejniece, Sandra, Griskevicius, Laimonas, Thielen, Noortje, Sacha, Thomas, Hellmann, Andrzej, Turkina, Anna, Zaritskey, Andrey, Bogdanovic, Andrija, Sninska, Zuzana, Zupan, Irena, Casado, Felipe, Simonsson, Bengt, Clark, Richard E., Saussele, Susanne, Hochhaus, Andreas, Hehlmann, Ruediger

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: